• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice.用格里菲斯菌素封闭1型人类免疫缺陷病毒糖蛋白120上的甘露糖部分,可增强小鼠对这两种蛋白的抗体反应。
AIDS Res Hum Retroviruses. 2012 Feb;28(2):206-14. doi: 10.1089/aid.2011.0101. Epub 2011 Jul 27.
2
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.酶促去除甘露糖部分可增强体内对HIV-1 gp120的免疫反应。
Virology. 2009 Jun 20;389(1-2):108-21. doi: 10.1016/j.virol.2009.04.001. Epub 2009 May 2.
3
Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin.去除 gp120 上的两个高甘露糖型 N-连接聚糖可使人类免疫缺陷病毒 1 对碳水化合物结合剂 griffithsin 产生很大的抗性。
J Gen Virol. 2011 Oct;92(Pt 10):2367-2373. doi: 10.1099/vir.0.033092-0. Epub 2011 Jun 29.
4
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.甘露糖特异性凝集素 griffithsin 与 HIV-1 gp120 的结合暴露了 CD4 结合位点。
J Virol. 2011 Sep;85(17):9039-50. doi: 10.1128/JVI.02675-10. Epub 2011 Jun 22.
5
Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.格里菲辛在 gp120 糖基化改变时保持抗 HIV-1 效力,并与广泛中和抗体 PGT121 和 PGT126 互补。
Antimicrob Agents Chemother. 2019 Dec 20;64(1). doi: 10.1128/AAC.01084-19.
6
Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.HIV-1 型 C 亚型 gp120 上富含甘露糖的糖基化模式及其对凝集素、Griffithsin、Cyanovirin-N 和 Scytovirin 的敏感性。
Virology. 2010 Jun 20;402(1):187-96. doi: 10.1016/j.virol.2010.03.021. Epub 2010 Apr 13.
7
The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.单个碳水化合物结合位点在强效抗 HIV 凝集素 griffithsin 功能中的作用。
Mol Pharm. 2012 Sep 4;9(9):2613-25. doi: 10.1021/mp300194b. Epub 2012 Aug 21.
8
Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicity.信号肽交换改变 HIV-1 包膜抗原性和免疫原性。
Front Immunol. 2024 Sep 24;15:1476924. doi: 10.3389/fimmu.2024.1476924. eCollection 2024.
9
Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.经工程改造以表达α-1,3-半乳糖基-β-1,4-N-乙酰葡糖胺-R表位的人免疫缺陷病毒gp120免疫原性增强。
J Virol. 2006 Jul;80(14):6943-51. doi: 10.1128/JVI.00310-06.
10
The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism.格里菲辛二聚体是高效抑制 HIV-1 所必需的:证据表明,它通过改变 gp120 的结构来发挥作用,这是格里菲辛二聚体机制的一部分。
Antimicrob Agents Chemother. 2013 Aug;57(8):3976-89. doi: 10.1128/AAC.00332-13. Epub 2013 Jun 10.

引用本文的文献

1
The Antiviral Potential of Algal Lectins.藻类凝集素的抗病毒潜力。
Mar Drugs. 2023 Sep 28;21(10):515. doi: 10.3390/md21100515.
2
Revisiting the role of cyanobacteria-derived metabolites as antimicrobial agent: A 21st century perspective.重新审视蓝藻衍生代谢产物作为抗菌剂的作用:21世纪的视角。
Front Microbiol. 2022 Nov 18;13:1034471. doi: 10.3389/fmicb.2022.1034471. eCollection 2022.
3
Myomedin scaffold variants targeted to 10E8 HIV-1 broadly neutralizing antibody mimic gp41 epitope and elicit HIV-1 virus-neutralizing sera in mice.靶向 10E8 HIV-1 广谱中和抗体模拟表位的肌抑素支架变体,并在小鼠中引发 HIV-1 病毒中和血清。
Virulence. 2021 Dec;12(1):1271-1287. doi: 10.1080/21505594.2021.1920251.
4
Antiviral Potential of Algal Metabolites-A Comprehensive Review.藻类代谢产物的抗病毒潜力——全面综述。
Mar Drugs. 2021 Feb 6;19(2):94. doi: 10.3390/md19020094.
5
The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals.藻类生物技术生产抗病毒化合物和生物制药的潜力。
Molecules. 2020 Sep 4;25(18):4049. doi: 10.3390/molecules25184049.
6
Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?Env 例外主义:HIV-1Env 糖蛋白为何为非典型免疫原?
Cell Host Microbe. 2020 Apr 8;27(4):507-518. doi: 10.1016/j.chom.2020.03.018.
7
Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin.铁氧化物纳米颗粒上的 HIV-1 包膜糖蛋白 SOSIP 三聚体诱导的中和抗体可能会被甘露糖结合凝集素损害。
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01883-19.
8
Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application.红藻源高活性广谱抗病毒凝集素 Griffithsin:从发现到临床应用。
Mar Drugs. 2019 Oct 6;17(10):567. doi: 10.3390/md17100567.
9
The Coming Age of Insect Cells for Manufacturing and Development of Protein Therapeutics.昆虫细胞用于蛋白质治疗药物制造与开发的新时代即将来临。
Ind Eng Chem Res. 2018 Aug 8;57(31):10061-10070. doi: 10.1021/acs.iecr.8b00985. Epub 2018 Jul 9.
10
Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.糖基化修饰 RV144 疫苗试验中使用的 gp120 免疫原可提高与广泛中和抗体的结合能力。
PLoS One. 2018 Apr 24;13(4):e0196370. doi: 10.1371/journal.pone.0196370. eCollection 2018.

本文引用的文献

1
How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?如何提高1型艾滋病毒包膜蛋白(HIV-type-1-Env)的免疫原性以促进基于抗体的疫苗开发?
AIDS Res Hum Retroviruses. 2012 Jan;28(1):1-15. doi: 10.1089/aid.2011.0053. Epub 2011 May 20.
2
Is developing an HIV-1 vaccine possible?开发 HIV-1 疫苗是否可行?
Curr Opin HIV AIDS. 2010 Sep;5(5):362-7. doi: 10.1097/COH.0b013e32833d2e90.
3
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.疫苗投递:大小、几何形状、动力学和分子模式的问题。
Nat Rev Immunol. 2010 Nov;10(11):787-96. doi: 10.1038/nri2868. Epub 2010 Oct 15.
4
Monomerization of viral entry inhibitor griffithsin elucidates the relationship between multivalent binding to carbohydrates and anti-HIV activity.病毒进入抑制剂 Griffithsin 的单体化阐明了多价结合碳水化合物与抗 HIV 活性之间的关系。
Structure. 2010 Sep 8;18(9):1104-15. doi: 10.1016/j.str.2010.05.016.
5
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.免疫缺陷病毒的囊膜糖蛋白几乎完全是寡甘露糖抗原。
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13800-5. doi: 10.1073/pnas.1006498107. Epub 2010 Jul 19.
6
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.HIV-1 包膜糖蛋白缺乏复杂的 N-聚糖可保持蛋白构象和进入功能。
Virology. 2010 Jun 5;401(2):236-47. doi: 10.1016/j.virol.2010.02.019. Epub 2010 Mar 21.
7
Rational antibody-based HIV-1 vaccine design: current approaches and future directions.基于理性抗体的 HIV-1 疫苗设计:当前方法和未来方向。
Curr Opin Immunol. 2010 Jun;22(3):358-66. doi: 10.1016/j.coi.2010.02.012. Epub 2010 Mar 17.
8
Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans.多糖模拟广泛中和抗 HIV 抗体 2G12 的表位,诱导针对自身寡甘露糖聚糖的增强抗体反应。
Glycobiology. 2010 Jul;20(7):812-23. doi: 10.1093/glycob/cwq020. Epub 2010 Feb 24.
9
Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.抗病毒蛋白格里菲斯辛对冠状病毒科新兴病毒的广谱体外活性和体内疗效。
J Virol. 2010 Mar;84(5):2511-21. doi: 10.1128/JVI.02322-09. Epub 2009 Dec 23.
10
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.酶促去除甘露糖部分可增强体内对HIV-1 gp120的免疫反应。
Virology. 2009 Jun 20;389(1-2):108-21. doi: 10.1016/j.virol.2009.04.001. Epub 2009 May 2.

用格里菲斯菌素封闭1型人类免疫缺陷病毒糖蛋白120上的甘露糖部分,可增强小鼠对这两种蛋白的抗体反应。

Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice.

作者信息

Banerjee Kaustuv, Michael Elizabeth, Eggink Dirk, van Montfort Thijs, Lasnik Amanda B, Palmer Kenneth E, Sanders Rogier W, Moore John P, Klasse Per Johan

机构信息

Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York 10021, USA.

出版信息

AIDS Res Hum Retroviruses. 2012 Feb;28(2):206-14. doi: 10.1089/aid.2011.0101. Epub 2011 Jul 27.

DOI:10.1089/aid.2011.0101
PMID:21793733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3275927/
Abstract

To assess the influence of mannosylated glycans on the immunogenicity of human immunodeficiency virus type 1 (HIV-1) Env proteins, we immunized mice with monomeric gp120 in the presence and absence of the mannose-binding protein, griffithsin (GRFT). For comparison, other groups of mice received the nonglycosylated HIV-1 Gag protein, with and without GRFT. Coimmunization with GRFT increased the anti-gp120 IgG reactivity significantly, but had no effect on the anti-Gag response. We also investigated the IgG response to GRFT and found that gp120, but not Gag, enhanced its immunogenicity. For both proteins, IgG1 antibodies dominated the IgG response, with IgG2b as the next most prevalent subclass. We conclude that gp120-GRFT complexes are more immunogenic than the free proteins, for both components, and that occluding the mannose moieties on monomeric gp120 can improve the humoral immune response to this protein.

摘要

为了评估甘露糖基化聚糖对1型人类免疫缺陷病毒(HIV-1)Env蛋白免疫原性的影响,我们在有和没有甘露糖结合蛋白——格里菲斯菌素(GRFT)存在的情况下,用单体gp120免疫小鼠。为作比较,其他几组小鼠分别接受了无糖基化的HIV-1 Gag蛋白,同样分为有和没有GRFT的情况。与GRFT共同免疫显著增加了抗gp120 IgG反应性,但对抗Gag反应没有影响。我们还研究了对GRFT的IgG反应,发现gp120而非Gag增强了其免疫原性。对于这两种蛋白,IgG1抗体在IgG反应中占主导,IgG2b是其次最普遍的亚类。我们得出结论,对于两种成分而言,gp120-GRFT复合物比游离蛋白更具免疫原性,并且封闭单体gp120上的甘露糖部分可以改善对该蛋白的体液免疫反应。